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Abstract: After coronary catheterization, fever sometimes occurs, usually transiently. We 
report a very rare case that suggests persistent high fever and systemic inflammation might be 
caused by periaortitis induced by coronary catheterization including percutaneous coronary 
intervention.
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Case report
A 79-year-old man was admitted to our hospital because of a two-month history of effort 
angina. He had smoked 70 cigarettes daily for about 50 years until seven years ago and 
had been treated for hypercholesterolemia for more than 10 years. He felt perfectly well 
until the occurrence of effort angina. Five days before admission, multidetector-row 
computed tomography (MDCT) of the heart showed severe stenosis of the right coronary 
artery and no contrast enhancement of the thoracic aorta. Coronary angiography from 
the right femoral artery approach showed 90% stenosis of the right coronary artery 
segment 2, in which a drug-eluting stent (DES; sirolimus-eluting stent) was placed. 
Twelve hours after placement of the DES, he developed a 39 °C fever with chills and 
rigor. The fever continued, but physical examinations were normal. He had no arthritis 
or eruptions, including so-called “blue toes” in the extremities. Repeated chest X-rays, 
electrocardiogram and echocardiography were normal. Laboratory examinations 
showed raised C-reactive protein (CRP; normal value 0.25 mg/dL) of 20.1 mg/dL 
from 0.3 mg/dL five days before admission and white blood cell count was 8600/µL 
without eosinophilia. Plasma levels of cytokines such as interleukin-6 (IL-6) (normal 
value 4.0 pg/mL), IL-8 (normal value 2.0 pg/mL) and tumor necrosis factor-α 
(TNF-α) (normal value 0.6–2.8 pg/mL) were significantly increased (25.7 pg/mL, 
12.9 pg/mL, 3.4 pg/mL, respectively). Antinuclear antibody (160 times, normal 
value 40 times) and rheumatoid factor (640 times, normal value 40 times) were 
positive. Repeated cultures of blood, urine, and sputum were all negative.
On the 12th day, a contrast-enhanced computed tomography (CT) was performed 
and a 3.3 cm infrarenal abdominal aortic aneurysm (AAA) was found, of which the 
maximum wall thickness was 8 mm with periaortic dirty fat signs. The periaortic 
contrast-enhancement from the ascending thoracic aorta including the branches of the 
aortic arch to the common iliac arteries, noted abnormalities which were especially 
pronounced from AAA to the common iliac arteries (Figure 1). The wall of aorta 
showed advanced atherosclerosis. The CT images suggested the periaortitis such as Vascular Health and Risk Management 2009:5 1060
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inflammatory abdominal aortic aneurysm (IAAA). He was 
treated with predonisolone 40 mg per day from the 14th day, 
resulting in complete resolution of fever over the next day. 
Additionally, CRP fell to 0.05 mg/dL and plasma levels of 
cytokines recovered to the normal range on the 28th day. 
The ANA and RA factor became negative. The CT on the 
38th day showed that the periaortic dirty fat sign and contrast-
enhancement disappeared (Figure 2). Predonisolone was 
withdrawn successfully one year after the treatment.
Discussion
After coronary catheterization, fever sometimes occurs 
usually transiently. The etiologies of fever are thought to be 
local and systemic infection, allergic reactions against con-
trast material, inflammatory reactions against hematoma, 
and embolic reactions such as blue toe syndrome. We thought 
the persistent high fever and systemic inflammation of this 
patient might be caused by an inflammatory response in the 
aortic wall, because the CT showed a finding of periaortitis 
and after predonisolone therapy the persistent high fever 
decreased, the increased CRP and cytokines recovered to the 
normal range, and the CT findings disappeared. It is known 
that the increase in systemic markers of inflammation 
including cytokines after percutaneous coronary interven-
tion is frequently attributed to the inflammatory stimulus 
associated with coronary artery injury during balloon infla-
tion and stent implantation1 and that, even after diagnostic 
coronary angiography, a systemic inflammatory response 
occurs in patients with stable effort angina.2 However, these 
kinds of systemic inflammations occur transiently without 
the persistent high fever.
The CT findings of periaortitis in this patient are similar 
to those of IAAA, which is one of the three forms of chronic 
periaortitis: 1) IAAA, 2) idiopathic retroperitoneal fibrosis, 
and 3) perianeurysmal retroperitoneal fibrosis which is a 
combination of the two disorders.3 The three forms of chronic 
periaortitis have similar histopathological characteristics, 
including adventitial and periadventitial inflammation, 
medial thinning and advanced atherosclerosis, and thus 
represent different manifestations of the same disease. The 
definitive diagnostic test of the chronic periaortitis is contrast-
enhanced CT scanning or gadolinium-enhanced magnetic 
resonance imaging. These demonstrate the periaortic soft 
tissue mass as a rind of abnormal tissue around the aorta, 
A
B C
Figure 1 contrast computed tomography showed the periaortic enhancement and dirty fat sign (white arrow), at the level of aortic arch and its branches A) abdominal 
aortic aneurysm, B) and common iliac arteries C).Vascular Health and Risk Management 2009:5 1061
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with a varying extent of spread, and the aorta is aneurysmal 
in IAAA.3 Iino and colleagues reported sensitivity of 83.3%, 
specificity of 99.7%, and accuracy of 93.7% for a diagnosis 
of IAAA using CT scanning.4 We do not have any histo-
pathological evidence of periaortitis, but the CT images of 
this patient showed the periaortic contrast enhancement from 
the ascending thoracic aorta including the branches of the 
aortic arch to the common iliac arteries, which was espe-
cially pronounced from AAA to the common iliac arteries 
and this periaortic contrast enhancement might be the major 
feature that distinguishes inflammatory from atherosclerotic 
AAA. Although the etiology of IAAA is unknown, IAAA is 
thought to be a consequence of local inflammatory reaction 
to antigens such as oxidized low-density lipoproteins (LDL) 
and ceroid (a lipoproteic polymer that results from LDL 
oxidation), which are often found in the advanced atheroscle-
rotic plaques. This causes antigen–antibody reactions concen-
trated in the media and adventitia, leading to inflammation 
and fibrotic proliferation around the aorta. On the other hand, 
patients with IAAA often have systemic symptoms, raised 
acute phase reactants, and positive autoantibodies and the 
inflammatory process not only involves the abdominal aorta 
but also the thoracic aorta and their branches3 as noted with 
this patient. The evaluation of chronic periaortitis by posi-
tron emission tomography showed a vascular inflammatory 
process mainly localized to the abdominal aorta and/or to the 
common iliac arteries, but the involvement of the thoracic 
aorta and its branches has been observed in 43% of chronic 
periaortitis patients.5 These suggest that IAAA could be a 
systemic autoimmune disease as seen in systemic vasculitis 
such as aortitis syndrome.3,5 In this patient, we presume that 
the atherosclerotic plaques of the aorta, especially in the 
infrarenal AAA could be stimulated locally by the catheters 
during the cardiac catheterization, causing activation of the 
antigen–antibody reaction from thoracic to abdominal aorta 
and their branches as described above, and resulted in acute 
systemic inflammatory responses including high fever.
In this patient before admission, systemic inflammation 
was not seen and the MDCT of the heart showed no signs 
of periaortitis at the level of the thoracic aorta, however an 
abdominal aortic CT was not performed. Therefore, it is not 
clear whether the AAA in this patient might be an asymptom-
atic early phase of IAAA without retroperitoneal fibrosis or 
only an advanced atherosclerotic AAA. Because it is known 
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Figure 2 contrast computed tomography three weeks after steroid therapy at the level of aortic arch and its branches A) abdominal aortic aneurysm, B) and common 
iliac arteries C).Vascular Health and Risk Management 2009:5
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that the inflammatory variant is seen in 5% to 10% of all cases 
of AAA, IAAA is not uncommon6 and pathological findings 
support that periaortitis can precede idiopathic retroperitoneal 
fibrosis.3 Asymptomatic early phase of IAAA might be eas-
ily activated to periaortitis by catheter stimulation and also 
by nonspecific inflammatory reactions such as a cytokines 
storm triggered by stent implantation, which was seen in this 
case. Therefore, careful observation of a patient is important 
because of the possibility of early phase of IAAA.
There are some reports about secondary IAAA induced 
by some medications (methysergide, methyldopa, amphet-
amines, cocaine, and beta-blockers), malignant diseases, 
infections, radiotherapy, and surgery (lymphadenectomy, 
colectomy, hysterectomy, aortic aneurysmectomy),3 none 
of which were related to this patient. There had not been 
any reports about secondary IAAA related to endovas-
cular treatment, but recently, there are some reports that 
endovascular therapy of AAA also had a severe and rare 
complication of IAAA.7,8 To our knowledge, this patient 
might be the first case of secondary periaortitis induced by 
the coronary catheterization and percutaneous coronary 
intervention.
In conclusion, when persistent high fever and systemic 
inflammation occur after catheterization and usual etiologies 
of fever are not found, we should consider periaortitis, 
especially in patients with advanced atherosclerotic AAA.
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